Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
iShares $ Corp Bond ETF USD Dist
LQDA | US
37.31
USD-0.15
-0.40%
LQDA | US
Loading StockChartView...
About iShares $ Corp Bond ETF USD Dist
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
37.31
Open
37.40
High
37.74
Low
36.02
Liquidia Corporation a biopharmaceutical company develops manufactures and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville North Carolina.
View LessLQDA | US
Risk
52.9
Sharpe
2.51
Luna's Score
52/100
Recommendation
Hold
Luna says (LQDA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
Midcap (2B - 10B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
50.7%1 month
52.9%3 months
60.9%6 months
62.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
15.42
Debt to equity
0.05
Debt to assets
0.02
Ent. to EBITDA
-9.43
Ent. to rev.
56.39
PEG
-
Other Fundamentals
EBITDA
-95.84M
MarketCap
3.15B
MarketCap(USD)
3.15B
Div. yield
-
Op. margin
-743.29
Erngs. growth
-
Rev. growth
-23.50
Ret. on equity
-181.73
Short ratio
11.41
Short perc.
21.63
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
6.17
Range1M
7.19
Range3M
17.55
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.65
Price X volume
26.05M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -9.43 | 0.53 | Cheaper |
| Ent. to Revenue | 56.39 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 15.42 | 15.55 | Par |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 60.89 | 72.80 | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 3.15B | 3.66B | Par |
